Cas:1209289-08-6 2-Amino-5-bromo-3-ethynylpyrazine manufacturer & supplier

We serve Chemical Name:2-Amino-5-bromo-3-ethynylpyrazine CAS:1209289-08-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Amino-5-bromo-3-ethynylpyrazine

Chemical Name:2-Amino-5-bromo-3-ethynylpyrazine
CAS.NO:1209289-08-6
Synonyms:T6N DNJ BZ C1UU1 EE;5-Bromo-3-ethynylpyrazin-2-amine;2-Amino-5-bromo-3-ethynylpyrazine;2-Pyrazinamine, 5-bromo-3-ethynyl-;QC-6864;5-Bromo-3-ethynyl-2-pyrazinamine
Molecular Formula:C6H4BrN3
Molecular Weight:198.020
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:313.7±42.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.664
PSA:51.80000
Exact Mass:196.958847
LogP:1.73

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like T6N DNJ BZ C1UU1 EE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-3-ethynyl-2-pyrazinamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,QC-6864 Use and application,5-Bromo-3-ethynylpyrazin-2-amine technical grade,usp/ep/jp grade.


Related News: The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. 2-Amino-5-bromo-3-ethynylpyrazine manufacturer We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. 2-Amino-5-bromo-3-ethynylpyrazine supplier We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 2-Amino-5-bromo-3-ethynylpyrazine vendor  The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. 2-Amino-5-bromo-3-ethynylpyrazine factory The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.